JNTX-101

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameJNTX-101
Drug Alias Namealbumin encapsulated gemcitabine prodrugJNTX-101
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analoguesSmall molecules > Prodrug
Mechanisms of ActionRibonucleotide reductase inhibitorsDNA inhibitors
TargetsRibonucleotide reductaseDNA
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States Minor Outlying Islands
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanuary Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJanuary Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A